Literature DB >> 11906757

Distribution of pertussis antibodies among different age groups in Japan.

Toshifumi Konda1, Kazunari Kamachi, Masaaki Iwaki, Yasuko Matsunaga.   

Abstract

We examined the distribution of antibody levels against pertussis toxin (PT) and filamentous hemagglutinin (FHA) among a healthy Japanese population aged from 0 to 77 years. Levels of both antibodies in 1108 serum samples collected in 1994 from nine prefectures were assayed using polystyrene ball ELISA. The ratio of individuals positive (>or=10 ELISA U/ml) for anti-PT and anti-FHA antibodies at ages ranging from 0 to 3 years increased rapidly with the increase in the population vaccinated over three times with acellular pertussis (aP) vaccine. However, the ratio of those positive for anti-PT antibody tended to decrease until 6-8 years of age and to increase again from 9 to 19 years among the vaccinated population, although the ratio of individuals positive for anti-FHA antibody remained constant at 80-100% in children and adolescents over 3 years old. Moreover, positivity for anti-PT antibody was high (>or=50 ELISA U/ml) in some serum samples collected from adolescents and young adults, suggesting recent symptomatic or asymptomatic infection with circulating Bordetella pertussis. On the other hand, 50-60% of infants below 12 months of age was below the detection limit (1.0 ELISA U/ml) for anti-PT and anti-FHA antibodies, and most early infants were not vaccinated for pertussis. Since intermittent circulation of B. pertussis remains among the Japanese population, complete vaccination with aP vaccine for all infants should be highly recommended to prevent pertussis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11906757     DOI: 10.1016/s0264-410x(02)00045-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Bordetella pertussis IgG and IgA antibodies seroprevalence among 1-35 y-old population: the role of subclinical pertussis infection.

Authors:  Mohammed-Jafar Saffar; Ali-Reza Khalilian; Ali-Reza Rafee; Mohammed Reza Parsaei; Shadi Imanikhani; Jalil Shojaei; Hana Saffar
Journal:  Indian J Pediatr       Date:  2011-11-22       Impact factor: 1.967

2.  Immunogenicity and reactogenicity of two diphtheria-tetanus-whole cell pertussis vaccines in Iranian pre-school children, a randomized controlled trial.

Authors:  Saeed Zarei; Mahmood Jeddi-Tehrani; Mohammad Mehdi Akhondi; Hojjat Zeraati; Amir Ali Ferydonfar; Jalaledin Nasernia; Banafsheh Tavangar; Fazel Shokri
Journal:  Hum Vaccin Immunother       Date:  2013-02-26       Impact factor: 3.452

3.  Seroprevalence of IgG antibodies to pertussis toxin in the Slovene population.

Authors:  Maja Socan; Katarina Prosenc; Miljana Vegnuti
Journal:  Wien Klin Wochenschr       Date:  2006-06       Impact factor: 1.704

4.  Prevalence of high antibody titers of pertussis in Turkey: reflection of circulating microorganism and a threat to infants.

Authors:  Berrin Esen; Nilay Coplu; Demet Kurtoglu; Aysegul Gozalan; Levent Akin
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

5.  A high seroprevalence of antibodies to pertussis toxin among Japanese adults: Qualitative and quantitative analyses.

Authors:  Takumi Moriuchi; Nao Otsuka; Yukihiro Hiramatsu; Keigo Shibayama; Kazunari Kamachi
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.